Benjamin Looker - Net Worth and Insider Trading
Benjamin Looker Net Worth
The estimated net worth of Benjamin Looker is at least $177,366 dollars as of 2024-11-05. Benjamin Looker is the General Counsel of Esperion Therapeutics Inc and owns about 83,663 shares of Esperion Therapeutics Inc (ESPR) stock worth over $177,366. Details can be seen in Benjamin Looker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Looker has not made any transactions after 2023-04-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin Looker
Benjamin Looker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin Looker owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Benjamin Looker’s form 4 insider trades.
Insider Ownership Summary of Benjamin Looker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-04-19 | General Counsel |
Benjamin Looker Latest Holdings Summary
Benjamin Looker currently owns a total of 1 stock. Benjamin Looker owns 83,663 shares of Esperion Therapeutics Inc (ESPR) as of April 19, 2023, with a value of $177,366.
Latest Holdings of Benjamin Looker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-04-19 | 83,663 | 2.12 | 177,366 |
Holding Weightings of Benjamin Looker
Benjamin Looker Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin Looker has made a total of 2 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Esperion Therapeutics Inc is the sale of 1,290 shares on April 19, 2023, which brought Benjamin Looker around $1,638.
Insider Trading History of Benjamin Looker
- 1
Benjamin Looker Trading Performance
Benjamin Looker Ownership Network
Ownership Network List of Benjamin Looker
Ownership Network Relation of Benjamin Looker
Benjamin Looker Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Benjamin Looker is the General Counsel of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Benjamin Looker made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,679 shares made by Eric Warren , a net purchase of 5,450 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .
In summary, during the past 3 months, insiders sold 17,476 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 17,476 shares. During the past 18 months, 26,431 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 33,180 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Benjamin Looker Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin Looker. You might contact Benjamin Looker via mailing address: C/o Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga A6 L5l 1j9.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
